PROTEINA CO.,LTD. Logo

PROTEINA CO.,LTD.

A biotech firm analyzing protein interactions for drug and diagnostic development.

468530 | KO

Overview

Corporate Details

ISIN(s):
KR7468530001
LEI:
Country:
South Korea
Address:
서울특별시 구로구 디지털로33길 11 구로동, 에이스테크노타워8차 13층 1301호, 구로구

Description

PROTEINA CO., LTD. is a biotechnology company specializing in proteomics, with a core focus on analyzing protein-protein interactions (PPIs). The company's proprietary SPID (Single-molecule Protein Interaction Detection) platform provides real-time, high-resolution insights into protein complexes with exceptional sensitivity. This technology is applied to discover novel drug candidates, develop PPI biomarkers, and advance new approaches to disease diagnostics. PROTEINA aims to drive the development of next-generation precision therapies by revolutionizing the understanding of protein interactions.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-05-19 00:00
증권신고서(지분증권)
Korean 3.2 MB
2025-03-31 00:00
감사보고서 (2024.12)
Korean 516.2 KB
2024-04-04 00:00
감사보고서 (2023.12)
Korean 452.1 KB
2023-04-11 00:00
감사보고서 (2022.12)
Korean 476.1 KB

Automate Your Workflow. Get a real-time feed of all PROTEINA CO.,LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for PROTEINA CO.,LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for PROTEINA CO.,LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
Biotechnology company providing R&D and services for the life sciences sector.
Spain
IKM
2cureX AB Logo
Develops an IVD test using 3D tumoroids to predict patient response to cancer drugs.
Sweden
2CUREX
Abera Bioscience AB Logo
Develops mucosal vaccines using a proprietary Outer Membrane Vesicle (OMV) platform.
Sweden
ABERA
Clinical-stage biopharma developing therapeutics for oncology and viral diseases.
South Korea
203400
ABL Bio Inc. Logo
Develops bispecific antibody therapeutics for oncology and neurodegenerative diseases.
South Korea
298380
Abpro Holdings, Inc. Logo
Clinical-stage biotech developing antibody therapeutics for oncology and ophthalmology.
United States of America
ABP
Absci Corp Logo
A generative AI drug creation company developing biologic medicines.
United States of America
ABSI
Achiko AG Logo
A digital services platform for cross-border business compliance and engagement.
Switzerland
ACHI
Active Biotech Logo
Biotechnology company developing drugs for oncology and inflammatory eye disorders.
Sweden
ACTI
Adagene Inc. Logo
Clinical-stage biotech developing antibody-based immunotherapies for oncology.
United States of America
ADAG

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.